Search Results
You searched for "Merck" ( 316 results )
-
Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy
- Lunit to support MD Anderson researchers studying immune phenotype biomarkers for pembrolizumab treatment response SEOUL, South Korea, Oct. 27, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a research collaboration with The University of Texas MD Anderson Cancer Center to analyze the use of Merck's (known as MSD outside the US and Canada) Keytruda (pemb
PR Newswire Oct. 28, 2023
-
Merck shares digital solutions for chip industry
Merck Korea, the Korean unit of the German chemicals giant, shared the company’s solutions for the future semiconductor industry at an academic conference held by Alumninetzwerk Deutschland-Korea, Tuesday. Under the topic “Unlocking the potential of artificial intelligence and machine learning in semiconductor manufacturing,” Steven Eulig, head of business development for digital solutions at Merck Electronics, delivered a speech on the company’s digital insight. While th
Industry Sept. 20, 2023
-
This year's Merck Award winners announced
Merck Korea, the Korean unit of the German chemicals giant Merck, said Thursday that two Korean display specialists were named as the winners of its Merck Award this year during the International Meeting of Information Displays held at Bexco in Busan this week. Marking its 20th anniversary this year, the Merck Award recognizes scientists for their outstanding scientific contributions to display technology. This year, Jeong Jae-kyeong, a professor at Hanyang University, won the top honor, the Mer
Technology Aug. 24, 2023
-
iGrafx Recognized as a Leader in Process Intelligence Software by Independent Research Firm
PORTLAND and TUALATIN, Ore., Aug. 3, 2023 /PRNewswire/ -- iGrafx, a leading provider in digital business transformation and intelligent process management, announces its recognition as a Leader in The Forrester Wave™: Process Intelligence Software, Q3 2023 report. iGrafx achieved the highest possible ranking in eleven criteria, including vision, process simulation, process metrics, process documentation and modeling, and pricing flexibility and transparency. The Forrester Wave assess
PR Newswire Aug. 3, 2023
-
BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program
Recognition of outstanding in-vivo outcomes from a lead RNA program in CNS Underpinned by proprietary IV-formulated, Brain-targeting Ribonucleic Acid Interference (RNAi) Nanomedicine (BTRiNTM) platform BIORCHESTRA to receive in-kind products and services from Merck Group CAMBRIDGE, Mass. and DAEJEON, South Korea, July 17, 2023 /PRNewswire/ -- BIORCHESTRA, a biotherapeutics company focused on the treatment of rare and degenerative diseases within the Central Nervou
PR Newswire July 18, 2023
-
Brinc Unveils Debut Climate Tech Cohort For Summer 2023
The global debut of Brinc's Climate Tech cohort welcomes four startups focused on carbon dioxide removal (CDR) solutions Brinc strengthens its growing, long-term commitment to tackling sustainability challenges and maximizing impact by honing in on innovations that directly combat climate change. HONG KONG, July 6, 2023 /PRNewswire/ -- Brinc, a leading global venture accelerator, is excited to announce the debut cohort of its Climate Tech accelerator, where four startups kick off its Sum
PR Newswire July 6, 2023
-
[KH explains] Parents turn to growth hormone to give their children an edge
South Korea’s growth hormone deficiency treatment market has seen stunning growth in recent years, particularly with growing interest in children’s height among parents here. “I heard that there are three things that moms in Daechi-dong (Seoul’s infamous private education district) do for their children these days: teeth straightening, squint eye correction and growth hormone treatment,” a 36-year-old working mom living in Gyeonggi Province said on condition of anon
Technology June 14, 2023
-
Merck introduces enhanced barrier materials for OLED
Merck said Wednesday it introduced new barrier materials that offer superior flexibility, higher reliability and longer lifespan in flexible OLED devices, when compared to existing solutions. Fully flexible OLED displays utilized in foldable, rollable and stretchable devices require a reduction of about 60 percent of the display module’s thickness when compared to standard displays. But because OLEDs are highly susceptible to degradation by moisture and oxygen, an encapsulation or barrier
Industry May 31, 2023
-
Hummingbird Bioscience Announces HMBD-002 Trials in Progress Poster at ASCO Annual Meeting 2023
HMBD-002, a non-depleting, high-affinity anti-VISTA antibody, possesses key design features enabling robust anti-tumor activity in preclinical models, positioning it as a potentially important new therapy for VISTA-expressing cancers including triple-negative breast cancer and non-small cell lung cancer HMBD-002 is currently being assessed in a Phase 1 study to determine the recommended Phase 2 dose as a monotherapy and in combination with pembrolizumab Monotherapy escalation cohorts 1-
PR Newswire May 29, 2023
-
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial
Positive primary endpoint result of objective response rate (ORR) from the planned interim analysis of Phase II trial in advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJ). Top-line data of the final analysis from Phase II to be announced in the second half of next year. SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- Genome & Company (CEOs: Pae, Jisoo, Park, Hansoo), a global leading microbiome therapeutics developer, announced that this phase II trial (NCT0541936
PR Newswire May 20, 2023
-
Hummingbird Bioscience and Merck Enter Collaboration to Evaluate HMBD-001 In Squamous Non-Small Cell Lung Carcinoma
Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 mAb, in combination with cetuximab, an anti-EGFR mAb, in sqNSCLC HMBD-001 used as monotherapy and in combination with cetuximab has been shown to effectively inhibit tumor growth across various preclinical squamous cell carcinoma models SAN FRANCISCO, HOUSTON and SINGAPORE, May 15, 2023 /PRNewswire/ -- Hummingbird Bioscience, a da
PR Newswire May 15, 2023
-
Fertility Counts: Merck Launch New Initiative to Underscore the Importance of Sustainable Population Growth in APAC-Region
Fertility Counts seeks to highlight the socio-economic impact of low birth rates on Asia-Pacific (APAC) economies. New Fertility Policy Toolkit, designed by Economist Impact and supported by Merck, proposes evidence-based policy interventions to build more family-friendly societies in APAC. LONDON, May 15, 2023 /PRNewswire/ -- Merck, a leading science and technology company, today launched a new initiative, Fertility Counts, which seeks to address the social, economic and societal chal
PR Newswire May 15, 2023
-
Brinc Introduces 'Co-Founder', an AI-Powered Chatbot for Startups
Brinc introduces an AI-powered Google Chrome extension, Co-Founder, to provide answers to entrepreneurship-focused prompts via OpenAI's ChatGPT and Brinc's own extensive knowledge base Brinc's own LLM (large language model) covering its expertise across the life cycle of pre-seed to Series C startup company investments and acceleration will complement OpenAI's LLM Co-Founder, designed by founders for founders, is currently in its Alpha phase. Interested parties are welcome to apply for ac
PR Newswire May 9, 2023
-
SI GROUP APPOINTS TERRY WALSH AS SENIOR VICE PRESIDENT OF OPERATIONS
Walsh brings nearly 30 years of experience managing global operations THE WOODLANDS, Texas, May 8, 2023 /PRNewswire/ -- SI Group, a leading performance additives company, announced today the appointment of Terry Walsh as its Senior Vice President of Operations, effective immediately. Walsh has extensive experience in lean manufacturing, process improvement, and supply chain planning and will be responsible for overseeing SI Group's manufacturing and engineering operations globally. Walsh
PR Newswire May 9, 2023
-
PharmAbcine to participate in "BIO International Convention 2023"
DAEJEON, South Korea, May 8, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company will participate in the upcoming BIO International Convention 2023. Details of the events are as follows: Event: Event: BIO International Convention Date: June 5-8, 2023 Registration: https://www.bio.org/events/bio-international-convention/registration-in
PR Newswire May 9, 2023
-
Seoul shares almost flat amid Fed uncertainties; Korean won sharply up
South Korean stocks closed almost flat Thursday, after the US Federal Reserve spurned the possibility of an imminent end to the rate hike cycle and ruled out that a rate cut is unlikely to happen anytime soon. The local currency gained sharply against the US dollar. The benchmark Korea Composite Stock Price Index fell 0.46 points, or 0.02 percent, to 2,500.94. Trading volume was moderate at 797.8 million shares worth 9.85 trillion won ($7.43 billion), with decliners slightly outnumbering gainers
Market May 4, 2023
-
Merck to build bioprocessing plant in Korea
Merck, a leading science and technology company based in Germany, said Wednesday it plans to build a bioprocessing unit in Daejeon, South Korea. Under a three-way memorandum of understanding signed by the firm with Korea's Ministry of Trade, Industry and Energy and the government of Daejeon, they will discuss detailed plans for building the international pharmaceutical company’s new bioprocessing unit that can produce raw materials for drugs. The Trade Ministry and the Daejeon city go
Technology May 3, 2023
-
Merck Signs MoU with Ministry of Trade, Industry & Energy and Daejeon City for New Asia Pacific BioProcessing Production Center in South Korea
MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem Proposed bioprocessing facility to be based in Daejeon City Further collaboration aims to support emerging biotech companies and academic research DAEJEON CITY, South Korea, May 3, 2023 /PRNewswire/ -- Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with the Ministry of Trade, Industry and Energy (MOTIE), and Daejeon City for a new Asi
PR Newswire May 3, 2023
-
Brinc Announce Program to Support Singaporean Food Startups Seeking Mainland China Market Entry, in partnership with Enterprise Singapore
Introducing a landing pad program for commercially-ready food technology startups in Singapore looking to enter the Chinese market Applications for the first cohort are now open, targeting 2-3 companies per cohort Participants will be looking to expand within the mainland China market with alternative protein products and sustainable packaging solutions HONG KONG, April 25, 2023 /PRNewswire/ -- Brinc, a leading venture accelerator with a global sustainability mandate; and Enterprise
PR Newswire April 25, 2023
-
Brinc x Rho Impact Join Forces to Help Startups Quantify the Emissions Reduction Potential of their Technologies
Brinc startups to quantify their impact via Rho Impact's tools Rho Impact will provide a workshop on their tools, which can help startups appeal to venture capitalists (VCs) and customers by demonstrating the impact of their technology on fighting climate change HONG KONG, March 21, 2023 /PRNewswire/ -- Brinc, a global venture accelerator committed to creating a more sustainable, equitable and inclusive future; and Rho Impact, an ESG advisory and software company with roots dating back t
PR Newswire March 21, 2023
Most Popular
-
1
Tensions heighten ahead of first president-opposition chief meeting
-
2
Seoul to provide housing subsidy to married couples with newborns
-
3
[KH Explains] No more 'Michael' at Kakao Games
-
4
Rapper jailed after public street fight with another rapper
-
5
Woman gets suspended term for injuring boyfriend with knife
-
6
Samsung chief bolsters ties with Germany’s Zeiss
-
7
Nominee for chief of anti-corruption body pledges 'independence, effectiveness'
-
8
NewJeans pops out ‘Bubble Gum’ video amid troubles at agency
-
9
Med schools expect 1,500+ new admission slots next year
-
10
KT launches new mobile plans for foreign residents